Marcin Paduch
Papers
2
Total Citations
153
H-Index
2
About
Marcin Paduch is a leading figure in the development of high-throughput platforms for generating recombinant antibodies, a field critical to both basic research and clinical applications. His work addresses a fundamental bottleneck in biology: the need for renewable, validated antibody reagents. Paduch’s most impactful contribution, a 2015 paper with 120 citations, describes an industrialized platform that successfully produced validated recombinant antibodies for 346 transcription factors, demonstrating a scalable solution to replace traditional, non-renewable monoclonal antibodies. He further advanced the field with a 33-citation paper on scalable high-throughput selection from phage-displayed synthetic antibody libraries, offering an alternative to conventional hybridoma technologies. By engineering systems that combine antigen generation with antibody selection, Paduch has helped create permanent, renewable resources for the scientific community. His work is notable for its practical impact on reproducibility and reagent accessibility, making him a key innovator in the push toward standardized, recombinant antibody tools for proteome-wide studies.
Research Focus
Key Achievements
Top Papers
- 1A High Through-put Platform for Recombinant Antibodies to Folded Proteins120 citations · 2015
- 2